What is the difference between Palmitoyl Tripeptide-1 and GHK-Cu?

Both contain the GHK tripeptide sequence. GHK-Cu combines GHK with a copper ion and is used both topically and as a research injectable. Palmitoyl Tripeptide-1 conjugates GHK with palmitic acid for optimised topical penetration. GHK-Cu has broader research applications, while Palmitoyl Tripeptide-1 is specifically designed for cosmetic anti-ageing.

What is Matrixyl 3000?

Matrixyl 3000 is a branded combination of Palmitoyl Tripeptide-1 and Palmitoyl Tetrapeptide-7, developed by Sederma. The combination provides both collagen-stimulating (matrikine) and anti-inflammatory effects, offering a comprehensive anti-ageing approach in a single peptide complex.

How long does it take to see results?

Clinical studies typically show measurable improvements after 2-4 months of consistent twice-daily application. Some users report improvements in skin texture and hydration within 4-6 weeks, while wrinkle depth reduction requires longer consistent use.

Can Palmitoyl Tripeptide-1 replace Botox?

No. Palmitoyl Tripeptide-1 stimulates collagen production for gradual skin improvement, while Botox (botulinum toxin) temporarily paralyses muscles to prevent expression lines. They work through completely different mechanisms and produce different types of results. Some people use both as complementary approaches.

Is this peptide safe for sensitive skin?

Palmitoyl Tripeptide-1 is generally very well tolerated, even by sensitive skin types. It is non-irritating in standard dermatological testing. However, individual sensitivities can occur with any cosmetic ingredient. Patch testing is recommended for very sensitive skin.

Can I use this with retinol?

Yes, Palmitoyl Tripeptide-1 is compatible with retinol and retinoids. The combination may be complementary—retinol increases cell turnover while the peptide stimulates collagen production. Introduce gradually to avoid irritation, particularly when starting retinol.

Fact-checked by the Peptide Authority Editorial Board · Last reviewed: 2026-02-22

Share:X Post LinkedIn

Cosmetic Peptides•Updated 2026-02-22•4 min read

What Is Palmitoyl Tripeptide-1? Benefits, Research & Safety

A lipopeptide signal peptide that mimics collagen breakdown fragments to stimulate new collagen and elastin production for anti-ageing skincare.

Also known as:

Pal-GHK

Palmitoyl Oligopeptide

Biopeptide CL

Educational Content Only: This page provides research-based information for educational purposes. Palmitoyl Tripeptide-1 is not an approved medicine. This is not medical advice. Always consult a qualified healthcare professional.

Quick Facts

Overview

Palmitoyl Tripeptide-1 (Pal-GHK) is a synthetic lipopeptide consisting of the tripeptide glycine-histidine-lysine (GHK) conjugated with palmitic acid for enhanced skin penetration. It belongs to the matrikine class of cosmetic peptides—signal peptides that mimic the fragments produced during collagen breakdown to stimulate new collagen synthesis. The GHK sequence is the same found in the copper peptide GHK-Cu, but in Palmitoyl Tripeptide-1, the palmitic acid conjugation replaces the copper ion, optimising the molecule for topical skincare delivery. This lipopeptide approach enhances penetration through the skin's lipid barrier while maintaining the signalling properties of the GHK sequence. Palmitoyl Tripeptide-1 is widely used in professional anti-ageing skincare formulations, often in combination with Palmitoyl Tetrapeptide-7 (the combination marketed as Matrixyl 3000). It represents one of the most commercially successful cosmetic peptides with extensive in vitro and clinical evidence for anti-ageing effects. This peptide is a cosmetic ingredient, not a pharmaceutical. It is used in topical skincare products and does not require prescription.

Discovery & History

Palmitoyl Tripeptide-1 was developed through cosmetic peptide research in the early 2000s, building on the understanding that collagen degradation fragments (matrikines) serve as signals to stimulate new collagen production. The GHK sequence had been identified as a key signalling tripeptide in wound healing and tissue remodelling research. Sederma, a French cosmetic ingredients company, developed the palmitoylated version to improve topical bioavailability. The palmitic acid conjugation was a key innovation, enabling the hydrophilic peptide to penetrate the skin's lipid-rich stratum corneum. The combination with Palmitoyl Tetrapeptide-7 was marketed as Matrixyl 3000, becoming one of the most widely adopted peptide complexes in cosmetic anti-ageing formulations globally. Clinical studies demonstrated visible improvements in wrinkle depth and skin firmness.

Mechanism of Action

Palmitoyl Tripeptide-1 works through matrikine signalling: **Matrikine Signalling** The GHK sequence mimics the fragments produced when collagen is broken down by matrix metalloproteinases (MMPs). These fragments serve as "alarm signals" that trigger fibroblasts to produce new collagen, effectively turning the natural degradation signal into a regenerative stimulus. **Collagen Stimulation** Activates fibroblasts to increase production of Type I collagen—the primary structural protein responsible for skin firmness and resistance to wrinkling. **Elastin Support** In addition to collagen, Palmitoyl Tripeptide-1 may stimulate elastin production, supporting skin elasticity and resilience. **Glycosaminoglycan Production** Research suggests the peptide promotes production of glycosaminoglycans (including hyaluronic acid) in the dermal extracellular matrix, supporting skin hydration and volume. **Enhanced Penetration** The palmitic acid conjugation enables the peptide to cross the stratum corneum lipid barrier, reaching the dermis where fibroblasts reside. This is critical for a topical peptide to exert biological effects.

[Molecular Structure Diagram Placeholder]

Researched Benefits

Based on preclinical and clinical research findings:

1
Stimulation of Type I collagen synthesis in fibroblasts
2
Visible reduction in wrinkle depth in clinical studies
3
Improvement in skin firmness and elasticity
4
Enhanced extracellular matrix production
5
Synergistic effects when combined with Palmitoyl Tetrapeptide-7 (Matrixyl 3000)
6
Good skin tolerability with minimal irritation potential

Theoretical Dosing & Protocols

⚠️ Educational Only: The following information is derived from research literature and is not a prescription or recommendation. No standardised human dosing exists. Always consult a qualified healthcare professional.

Theoretical Dosage	Typical concentration in skincare: 2-5% of the peptide complex (Matrixyl 3000)
Frequency	Twice daily application (morning and evening)
Duration	Clinical studies typically 2-4 months; ongoing use for maintained benefits
Notes	Applied topically as part of serum or moisturiser formulations. Best results with consistent, long-term use. Often combined with Palmitoyl Tetrapeptide-7 and other active ingredients.

Administration Routes

Routes studied in research settings (educational only):

Topical (serums, creams, moisturisers)

Half-Life	Stability
Topical application; systemic pharmacokinetics not relevant. Effects depend on continuous application.	Stable in properly formulated cosmetic products. Protected from excessive heat and light.

Safety Profile & Known Risks

Commonly Reported Side Effects

Very well tolerated
Rare mild skin irritation in sensitive individuals

Rare Risks & Concerns

Allergic contact dermatitis (very rare)
Not associated with systemic side effects

Contraindications

Known hypersensitivity to the ingredient
Open wounds or broken skin (apply to intact skin only)

UK & EU Regulatory Context

🇬🇧 United Kingdom

Regulated as a cosmetic ingredient. Widely available in skincare products without prescription.

🇪🇺 European Union

Listed in the EU cosmetic ingredient database (CosIng). Permitted in cosmetic formulations.

Classified as a cosmetic ingredient globally. Not a pharmaceutical or research peptide. Widely used in commercial anti-ageing products.

Clinical Studies Summary

Matrixyl 3000 Clinical Efficacy Study

Clinical trial demonstrated that 2-month application of Matrixyl 3000 (Palmitoyl Tripeptide-1 + Palmitoyl Tetrapeptide-7) reduced wrinkle volume by up to 44% compared to baseline, with significant improvements in skin firmness and smoothness.

Sederma Clinical Data / International Journal of Cosmetic Science

In Vitro Collagen Stimulation

Cell culture studies demonstrated that Palmitoyl Tripeptide-1 significantly increased Type I collagen production by human dermal fibroblasts in a dose-dependent manner, confirming the matrikine signalling mechanism.

Experimental Dermatology

Looking for Palmitoyl Tripeptide-1?

Source research-grade Palmitoyl Tripeptide-1 from a trusted UK supplier — third-party tested with certificate of analysis.

View at Supplier

Frequently Asked Questions

Related Research Guides

Peptide Comparisons

Matrixyl vs GHK-Cu

Compare peptides

Argireline vs Matrixyl

Compare peptides

Combination Protocols

GHK-Cu + Matrixyl Collagen Synergy Stack

View protocol

Related Peptides

GHK-Cu

A naturally occurring copper-binding tripeptide researched for its roles in wound healing, skin regeneration, anti-ageing, and tissue remodelling.

Learn more

Matrixyl

A pioneering signal peptide that mimics natural collagen-boosting messengers, extensively validated in clinical studies for wrinkle reduction and skin firmness improvement.

Learn more

Argireline

A neuromodulating hexapeptide that reduces facial muscle contractions through SNARE complex inhibition, providing a topical alternative to botulinum toxin for expression line reduction.

Learn more

SNAP-8

An enhanced 8-amino acid version of Argireline with improved penetration and efficacy for reducing expression lines through SNARE complex modulation.

Learn more

Syn-Ake

A tripeptide that mimics the neuromuscular blocking effects of Temple Viper venom (waglerin-1), targeting nicotinic acetylcholine receptors to reduce expression lines.

Learn more

Explore More Peptides

Browse our comprehensive database of research-backed peptide profiles.

Fact-checked by the Peptide Authority Editorial Board · Last reviewed: 2026-02-22

Share:X Post LinkedIn

Cosmetic Peptides•Updated 2026-02-22•4 min read

What Is Palmitoyl Tripeptide-1? Benefits, Research & Safety

A lipopeptide signal peptide that mimics collagen breakdown fragments to stimulate new collagen and elastin production for anti-ageing skincare.

Also known as:

Pal-GHK

Palmitoyl Oligopeptide

Biopeptide CL

Quick Facts

Overview

Discovery & History

Mechanism of Action

[Molecular Structure Diagram Placeholder]

Researched Benefits

Based on preclinical and clinical research findings:

1
Stimulation of Type I collagen synthesis in fibroblasts
2
Visible reduction in wrinkle depth in clinical studies
3
Improvement in skin firmness and elasticity
4
Enhanced extracellular matrix production
5
Synergistic effects when combined with Palmitoyl Tetrapeptide-7 (Matrixyl 3000)
6
Good skin tolerability with minimal irritation potential

Theoretical Dosing & Protocols

Theoretical Dosage	Typical concentration in skincare: 2-5% of the peptide complex (Matrixyl 3000)
Frequency	Twice daily application (morning and evening)
Duration	Clinical studies typically 2-4 months; ongoing use for maintained benefits
Notes	Applied topically as part of serum or moisturiser formulations. Best results with consistent, long-term use. Often combined with Palmitoyl Tetrapeptide-7 and other active ingredients.

Administration Routes

Routes studied in research settings (educational only):

Topical (serums, creams, moisturisers)

Half-Life	Stability
Topical application; systemic pharmacokinetics not relevant. Effects depend on continuous application.	Stable in properly formulated cosmetic products. Protected from excessive heat and light.